Fennec Pharmaceuticals Stock Story
| FENC Stock | USD 9.57 0.13 1.34% |
About 66% of Fennec Pharmaceuticals' investor base is looking to short. The analysis of the overall investor sentiment regarding Fennec Pharmaceuticals suggests that many traders are alarmed. Fennec Pharmaceuticals' investor sentiment overview provides quick insight into current market opportunities from investing in Fennec Pharmaceuticals. The current market sentiment, together with Fennec Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Fennec Pharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Fennec Pharmaceuticals stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Fennec daily returns and investor perception about the current price of Fennec Pharmaceuticals as well as its diversification or hedging effects on your existing portfolios.
Fennec |
Requested story not found. it has been either deleted or moved. View all stories for Fennec Pharmaceuticals.
Fennec Pharmaceuticals Latest Timeline
Fennec Pharmaceuticals is listed for 9.57. About 15.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.6. Fennec Pharmaceuticals had not issued any dividends in recent years. The entity had 1:3 split on the 5th of September 2014.Check out Fennec Pharmaceuticals Hype Analysis, Fennec Pharmaceuticals Correlation and Fennec Pharmaceuticals Performance. For information on how to trade Fennec Stock refer to our How to Trade Fennec Stock guide.You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Complementary Tools for Fennec Stock analysis
When running Fennec Pharmaceuticals' price analysis, check to measure Fennec Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fennec Pharmaceuticals is operating at the current time. Most of Fennec Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Fennec Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fennec Pharmaceuticals' price. Additionally, you may evaluate how the addition of Fennec Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |
Is Fennec Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fennec Pharmaceuticals. If investors know Fennec will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fennec Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.60) | Revenue Per Share 0.8 | Quarterly Revenue Growth 5.342 | Return On Assets (0.30) | Return On Equity (10.06) |
The market value of Fennec Pharmaceuticals is measured differently than its book value, which is the value of Fennec that is recorded on the company's balance sheet. Investors also form their own opinion of Fennec Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Fennec Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fennec Pharmaceuticals' market value can be influenced by many factors that don't directly affect Fennec Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fennec Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Fennec Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fennec Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.